IN8BIO, INC. research brief
CIK 1740279
Generated Nov. 18, 2026, 6:44 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: NEW YORK New York. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Dec. 30, 2025 · D · 0001231919-25-000676 · Source evidence
Reported offering amount: 40239043 USD. Reported amount sold: 20119049 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “IN8BIO, INC. research brief,” CIK 1740279, retrieved Nov. 18, 2026, 6:44 p.m.. Cite the specific accessions used. No amounts have been summed.